Reverse rate dependence is a problematic property of antiarrhythmic drugs that prolong the cardiac action potential (AP). The prolongation caused by reverse rate dependent agents is greater at slow heart rates, resulting in both reduced arrhythmia suppression at fast rates and increased arrhythmia risk at slow rates. The opposite property, forward rate dependence, would theoretically overcome these parallel problems, yet forward rate dependent (FRD) antiarrhythmics remain elusive. Moreover, there is evidence that reverse rate dependence is an intrinsic property of perturbations to the AP. We have addressed the possibility of forward rate dependence by performing a comprehensive analysis of 13 ventricular myocyte models. By simulating populations of myocytes with varying properties and analyzing population results statistically, we simultaneously predicted the rate-dependent effects of changes in multiple model parameters. An average of 40 parameters were tested in each model, and effects on AP duration were assessed at slow (0. 2 Hz) and fast (2 Hz) rates. The analysis identified a variety of FRD ionic current perturbations and generated specific predictions regarding their mechanisms. For instance, an increase in L-type calcium current is FRD when this is accompanied by indirect, rate-dependent changes in slow delayed rectifier potassium current. A comparison of predictions across models identified inward rectifier potassium current and the sodium-potassium pump as the two targets most likely to produce FRD AP prolongation. Finally, a statistical analysis of results from the 13 models demonstrated that models displaying minimal rate-dependent changes in AP shape have little capacity for FRD perturbations, whereas models with large shape changes have considerable FRD potential. This can explain differences between species and between ventricular cell types. Overall, this study provides new insights, both specific and general, into the determinants of AP duration rate dependence, and illustrates a strategy for the design of potentially beneficial antiarrhythmic drugs.
Prolongation of the ventricular action potential (AP), the action of class III antiarrhythmic drugs, is an antiarrhythmic strategy with a checkered past. Theoretically, increasing the action potential duration (APD) should be antiarrhythmic; a longer APD will increase the refractory period of the myocardium, thereby inhibiting the pathological re-entry of excitation that underlies many arrhythmias. However, a large-scale clinical trial that tested the Class III antiarrhythmic d-sotalol demonstrated increased rather than decreased mortality with this agent, presumably due to increased ventricular arrhythmias [1]. Moreover, multiple lines of evidence implicate a long QT interval, the electrocardiographic marker for prolonged APD, in arrhythmogenesis, including the increased incidence of torsades de pointes (TdP) and sudden cardiac death in both congenital and acquired long QT syndromes [2]. Indeed, safety pharmacology screens routinely test for QT prolongation as an unwanted side effect of novel candidate pharmaceutics [3]. How can AP prolongation simultaneously be both antiarrhythmic in principle and an indicator of proarrhythmia in practice? More nuanced analyses have suggested that QT and AP prolongation are not per se arrhythmogenic, but become so when accompanied by reverse rate dependence [4]. Reverse rate dependent (RRD) action potential prolongation refers to the phenomenon that drugs will prolong the APD to a greater extent at slow heart rates than at fast [5]. RRD prolongation is an unfortunate yet common property of Class III antiarrhythmics. This is doubly problematic, as it not only weakens the ability of these drugs to suppress re-entrant tachyarrhythmias, but also, because of the exaggerated action at slow heart rates, increases proarrhythmic potential. The excessive increase in APD at slow heart rates, when the APD is naturally longer to begin with, allows for recovery of inactivated calcium channels, increasing the likelihood of an early afterdepolarization [6], a cellular event that can precipitate TdP [7]–[8]. This lack of efficacy at rapid rates and arrhythmogenic potential at slow rates makes reverse rate dependence undesirable and reduces the therapeutic potential of class III agents. An ideal class III agent would instead prolong APs in a forward rate dependent (FRD) manner. That is, it would prolong the APD at fast heart rates but induce minimal prolongation at slow heart rates [5]. Current class III agents prolong the APD primarily through inhibition of the rapid delayed rectifier K+ current (IKr), and IKr block specifically has been shown to be RRD [9]. Since inhibition of any repolarizing current, or accentuation of any depolarizing current, could theoretically prolong the APD and increase the refractoriness of the myocardium, targets other than IKr have been under investigation [10]. Yet FRD agents have remained elusive. In fact, not only have many drugs been shown to exhibit reverse rate dependence, there is evidence that RRD behavior is not unique to IKr-block, but instead occurs with multiple perturbations that affect the APD, including injection of membrane current [11]–[13]. Zaza has provided an elegant explanation, based on the rate of change of the membrane potential [14], for why multiple pharmacological agents exhibit RRD behavior. This idea is based on the observation that APD will be naturally shorter at faster than at slower heart rates in most mammals, including human, canine, and guinea pig. Because of the shortened APD, the rate of repolarization, dV/dt, will be larger in magnitude at faster rates. Zaza describes how a given change in membrane current that prolongs APD will inherently have a smaller effect when working against a larger rate of repolarization. Thus, at faster heart rates, any AP-prolonging perturbation must act against a stronger repolarizing force, and this attenuates the resulting prolongation, resulting in reverse rate dependence [14]. This explanation, combined with the RRD behavior seen in response to a variety of agents, has led to the idea that this is an inherent property of ventricular preparations [13]. The implication that reverse rate dependence is an inherent property of myocytes leads to the question of whether the search for an effective class III agent is hopeless. In other words, are all antiarrhythmic strategies based on prolonging APD destined to fail due to reverse rate dependence? In the present study, we have addressed this question by performing a comprehensive analysis of ventricular myocyte models. By simulating heterogeneous populations of ventricular myocytes and analyzing population results statistically [15], we simultaneously predicted the rate-dependent effects of changes to all model parameters. Our results show that, while ventricular cell models often display reverse rate dependence, a variety of ionic current perturbations do in fact produce the desired forward rate dependence. The perturbations we identify provide potential drug targets for FRD APD prolongation, and further simulations of these perturbations provide insight into how FRD behavior can be produced. Additionally, a comparison between mathematical models demonstrates that rate-dependent changes in AP shape play a central role in determining a myocyte' s capacity for forward versus reverse rate dependence. Through these simulation results, this study provides new insight into the determinants of APD rate dependence and illustrates a strategy for the design of potentially beneficial antiarrhythmic drugs.
Reverse rate dependence occurs when a perturbation that changes APD does so to a greater extent at a slow heart rate than at a fast. In other words, as the heart rate slows, the degree of change to the APD increases. Reverse rate dependence has been observed experimentally in response to both several APD altering drugs and to injection of current [12]–[13], and has also been seen in simulation studies [16]. We first confirmed that RRD AP prolongation can be produced in ventricular cell models when parameters representing ion channel properties are altered. Figure 1 shows two examples simulated with the LR09 guinea pig model [17]: decreased slow-delayed rectifier maximal conductance (parameter GKs, Figure 1A), and increased L-type Ca2+ channel maximal conductance (parameter GCaL, Figure 1B). As expected, both perturbations (a decrease in repolarizing current and an increase in depolarizing current, respectively), prolong the AP. In either case, this prolongation also displays clear reverse rate dependence: the AP prolongation is greater at slow pacing (0. 2 Hz) than at fast (2 Hz) for each degree of perturbation, in both absolute and in percent change. Similar effects can be produced in all models that were tested. In order to understand RRD behavior more comprehensively, we took a systematic approach to analyze the influence of the dozens of parameters that characterize the expression levels and gating of the ion channels in ventricular cell models. We performed a parameter sensitivity analysis, as described previously [15] and in Methods, that allowed us to examine this multitude of parameters in concert and to extract the influence of each on the APD. For each ventricular cell model, we generated a virtual population of hundreds of model variants, in which each individual is defined by a randomly varied set of parameter values. We simulated each model variant at both a fast pacing rate of 2 Hz and a slow pacing rate of 0. 2 Hz. We applied this analysis to 7 independent ventricular cell models: TNNP04 [18], TP06 [19], OVVR [20], FMG [21], HR [22], LR91 [23], and LR09 [17] (abbreviations defined in Methods). Additionally, in the human models (TNNP04, TP06, and OVVR), we conducted the analysis on each of the 3 transmural tissue layers: epicardial, mid-myocardial, and endocardial. In all, 13 ventricular myocyte formulations were tested. Distributions of APD across the virtual populations, and a comparison with experimental APD data, are displayed in Figure 2. This shows that faster pacing led to shorter APs in most models, with the notable exceptions of LR91 and TNNP04. This also shows that some models, such as HR, FMG, and OVVR, did notably well in matching the experimentally-observed range of APD. To quantify the rate dependence of how the model parameters influence APD, we performed multivariable regression analysis on the population data to statistically relate the model parameters to the simulation outputs. The accuracy of this linear approximation in describing the population behavior has been previously demonstrated [15], [24]–[26] and is quantified in Table 1, which shows R2 values resulting from the each model' s regression analysis. This analysis generated two sensitivity values for each parameter, Bfast and Bslow, characterizing that parameter' s influence on the APD at the two rates. If the effect of a perturbation on APD is rate-dependent, the corresponding parameter sensitivity will differ with rate. We summarize this by calculating BRD, which indicates the difference between the parameter sensitivities at the two rates. Figure 3A illustrates some hypothetical possibilities. If the two parameter sensitivities are approximately equal (example b), then BRD is close to zero and changes in the parameter are essentially neutral with respect to rate. On the other hand, positive BRD indicates an RRD perturbation: altering that parameter changes the APD more at a slow rate (example c). Conversely, negative BRD indicates an FRD perturbation: changing that parameter affects the APD more at a fast rate (example a). Finally, example d is a parameter for which Bfast and Bslow have opposite signs. This indicates that perturbing the parameter will prolong the AP at one rate but shorten it at the other. As discussed in Methods, this behavior does not necessarily fit the RRD/FRD paradigm, but it does represent a perturbation that can lengthen the APD at fast pacing but not at slow. Thus we categorize such parameters with the FRD parameters by assigning a negative BRD. For a given ventricular cell model, the BRD plot summarizes the rate dependencies of that model' s parameters (Figure 3B). Figure 3C shows the results of this analysis in the TP06 epicardial model. Some parameters are strongly RRD, as expected, but, surprisingly, the majority of parameters are mildly FRD, and some are even strongly FRD. Simulations in which one parameter was varied at a time validate BRD as a quantification of the rate-dependence of a parameter. For example, Figure 3D shows that decreasing GKs prolongs the AP with reverse rate dependence, as predicted by that parameter' s large, positive BRD, whereas increasing GCaL prolongs the APD with forward rate dependence, as predicted by that parameter' s large, negative BRD. BRD was further validated as a measure of rate dependence through single-variable simulations of perturbations to other parameters (Figure S1). The distributions of BRD values varied greatly between models. Most models showed a preponderance of RRD parameters, consistent with the hypothesis that reverse rate dependence is intrinsic to any alteration to the APD [13]–[14]. For example, LR09 has mostly RRD parameters (Figure 4A). Of the parameters that are not RRD, most have small BRD magnitude, indicating minimal rate sensitivity. However, several models have a majority of FRD parameters. For instance, we found that most parameters in the HR model are FRD, including, in contrast to LR09, GCaL (Figure 4B). Furthermore, the parameters KNCX (maximal Na+-Ca2+ exchange current), GNa (maximal fast Na+ conductance), and KNaK (maximal Na+-K+ pump current) all displayed forward rate dependence in the HR model. Results obtained in all models studied are shown in Figures S1Figures S1–S13 in Text S2. The dramatic differences observed between models led us to wonder what characteristics of the models accounted for these divergent behaviors. We reasoned that if AP shape does not change with rate, then shorter APs at faster rates simply correspond to a faster rate of repolarization. In this case, prior studies have suggested that all perturbations may be inherently RRD [14]. Thus we hypothesized that the number of RRD versus FRD parameters may be related to the changes in AP shape observed with changes in pacing rate. Indeed, we observed that models with larger rate-dependent changes in AP shape have a stronger potential for FRD perturbations, whereas those with minimal rate-dependent changes in AP shape have primarily RRD parameters. For instance, the LR09 model, with almost exclusively RRD parameters (Figure 4A), shows little change in AP shape with rate (Figure 5A) whereas the HR model, with many FRD parameters (Figure 4B), exhibits a substantial change in AP shape with rate (Figure 5A). To determine if this was generally true across models, we quantified the degree of rate-dependent AP morphology change for each model by calculating the root mean square deviation (RMSD) between AP traces at slow and fast pacing (Figure S2). Before computing RMSD, the simulated AP at the fast rate was rescaled with respect to time to match the duration seen at the slow rate (see Text S1 for details). Each model' s capacity for FRD perturbations was quantified by the percent of that model' s parameters that are FRD. We found a strong positive correlation (R2 = 0. 8366) between the RMSD and the percentage of FRD parameters; that is, a greater change in AP shape corresponds to a greater capacity for forward rate dependence (Figure 5B). We found that the two canine models, HR and FMG, displayed both the highest degree of rate-dependent AP shape change and the highest proportion of FRD parameters. In the HR model, the rate-dependent AP shape change is largely due to the transient outward current (Ito), which is greater at slow pacing and creates the dramatic phase 1 notch seen at this rate. This effect is present but less prominent in the FMG model. Therefore, we hypothesized that blocking Ito in either model would: (1) decrease the rate-dependent AP shape change, and, consequently, (2) reduce the model' s capacity for forward rate dependence. We evaluated rate-dependent behaviors in the two models after blocking Ito (75% reduction of maximal conductance). This attenuated the phase 1 notch in either model, thereby resulting in a smaller rate-dependent change in AP shape (Figure S3A). This also resulted in a smaller percentage of FRD parameters in either model (Figure S3B). Thus, differences in Ito contribute substantially to differences between models. To examine the consistency of specific predictions across models, we performed two analyses. For these we selected a subset of parameters that are present in almost all models and that correspond to currents generally thought to be important in determining APD. Figure 6 illustrates the rate dependence of these parameters across all the models tested. For this display we do not compare magnitudes of rate dependence across models but instead show whether each parameter is RRD (red), FRD (blue), or non-rate dependent (NRD) (white) in each model. The results show that altering either the magnitude of slow delayed rectifier current (GKs) or the speed of its gating (pxs) produces RRD prolongation, suggesting that therapeutic targeting of this current may produce undesirable effects. In contrast, perturbing the magnitudes of either inward rectifier K+ current (GK1) or the Na+-K+ pump (KNaK) could produce desirable FRD behavior, although this was not true in all models. For the second analysis we ranked the parameters in each model from the most RRD parameter to the most FRD parameter. We then averaged the relative rank of these parameters across models to generate a rate-dependence consensus list (Table 2). This largely confirms the visual impression of Figure 6, that parameters related to IKs produce RRD behavior whereas IK1 and INaK may represent legitimate targets for producing FRD prolongation of the AP. To understand how a given perturbation affects the APD at different rates, we need to examine not only the ionic current directly affected by the perturbation, but all of the other ionic currents in the system. Each current may be indirectly affected by a perturbation, through changes to the AP shape or changes in intracellular ion concentrations, and the sum of their resulting behavior will produce the observed changes in APD. We developed an analysis method to identify which indirect effects of a perturbation may account for rate dependent AP prolongation. This involved integrating each current from the beginning to the end of the AP under four conditions: with and without the perturbation, at fast and slow rates. The change in the integrated current is denoted ΔQ. If a perturbation changes an integrated current by the same amount at both fast and slow rates, then the current does not contribute substantially to the perturbation' s rate dependence. However, if the change in the integrated current varies with rate, then the current may underlie the resulting rate dependence of how the perturbation affects the APD. For example, consider the hypothetical case illustrated in Figure 7. If a perturbation causes a large increase in an inward current, but exclusively at the slow rate, then this current would prolong the APD only at the slow rate, and contribute to reverse rate dependence. Thus by comparing the ΔQ at slow and fast rates, we can determine whether a particular current contributes to rate dependence. Using this analysis, we were able to identify indirectly-affected currents that are responsible for rate-dependent behavior. In the TP06 epicardial model, we investigated three ionic current perturbations that prolong the APD: an increase in ICaL current density (increased GCaL), slowing of IKs activation (decreased pxs), and shifting ICaL activation to more negative membrane potentials (decreased Vd). All of these changes prolong the APD, but each with a different rate dependence. Increased GCaL produces FRD changes, slower activation of IKs produces RRD changes, and shifting ICaL activation produces rate-neutral changes. To probe the mechanisms behind these differing rate dependencies, we examined the secondary effects of each perturbation by calculating ΔQ for each current (Figure 8A). This analysis revealed that IKs in particular displays distinctive rate-dependent behavior with each perturbation, indicating that changes in IKs contribute to the rate dependence of these specific perturbations. Thus, we examined changes in IKs time course produced by the different perturbations to gain insight into underlying mechanisms. Slowing the activation of IKs (decreasing pxs) reduced total IKs more at slow pacing compared to fast, causing greater AP prolongation at slow than at fast (Figure 8B, middle). This indicates that the RRD effects of slowing IKs activation depend directly on the rate-dependent behavior of IKs itself. Shifting the voltage dependence of ICaL activation, a NRD perturbation, caused a small increase in IKs, but the magnitude of the increase was similar at the two rates (Figure 8B, right). Thus, changes in IKs in this case do not contribute to rate-dependence, consistent with the overall NRD effects of this perturbation. In contrast, increasing GCaL led to an indirect increase in IKs, but with marked rate dependence (Figure 8B, left). Because IKs increases dramatically more at slow pacing than at fast, this current therefore contributes to the forward rate dependence of enhanced GCaL. We tested the hypothesis that changes in IKs underlie the forward rate dependence of increased GCaL through a “double perturbation analysis. ” This was done by conducting simulations in which we perturbed ICaL as before, but also blocked IKs. Indeed, 50% block of IKs attenuated the forward rate dependence of ICaL enhancement, and 80% block actually reversed it, resulting in RRD changes to the APD (Figure 8C). Hence, rate-dependent changes in IKs are critical for the FRD behavior of enhancing GCaL.
At a broad level, a primary finding is that the capacity for forward rate dependence correlates with the extent of rate-dependent changes in the AP contour. Models that exhibit small changes in AP shape with pacing rate have few FRD parameters whereas those that display dramatic changes in AP shape have many more possibilities for FRD perturbations. Further analysis suggests that transient outward current, Ito, is a major factor underlying the differences between models. For instance, in either the HR or the FMG canine model [21]–[22], blocking Ito attenuated, in parallel, both rate dependent changes in AP contour and the number of FRD parameters. Similarly, models of guinea pig myocytes [17], [23], which lack Ito, tended to show small rate dependent changes in AP shape and to have few FRD parameters. Finally, in all three human models [18]–[20], endocardial cells had both the lowest Ito and the fewest FRD parameters compared to mid-myocardial and epicardial myocytes. These observations indicate that the relationship between AP shape change and capacity for forward rate dependence is a general principle, and that Ito contributes prominently to differences between models. The large differences seen between models can both provide new insight into physiological differences and identify discrepancies that need to be resolved, as several recent studies have emphasized [31]–[33]. Most differences between models seem to reflect true physiological differences, such as between canine and guinea pig myocytes, with prominent and minimal Ito, respectively. On the other hand, differences between models representing the same species and tissue type indicate possible inaccuracies in specific model formulations. These differences can be seen in both global measures of behavior, such as the percentage of FRD parameters, and in specific predictions. For example, block of IKr had opposite rate-dependent effects in TP06 compared to OVVR. IKr block was the most RRD perturbation in OVVR (Figures S9–S11 in Text S2), but slightly FRD in TP06 (Figures S6–S8 in Text S2). These findings illustrate that results from a single model should be interpreted cautiously, and they demonstrate the strengths of identifying predictions that are consistent across several models (Figure 6, Table 2, and [26]). The large set of FRD parameters we identified in several models may appear at odds with the contention that reverse rate dependence is intrinsic [11]–[14]. These results, however, are in fact consistent with and complementary to those predictions. Intrinsic reverse rate dependence has been explained as a consequence of the inverse relationship between net membrane current and APD, whereby a change in membrane current will have a smaller effect on shorter compared with longer APs due to the relative differences in repolarization velocity [11], [14]. In the derivation of this relationship, APD changes with rate, but the AP contour is not otherwise modified. Moreover, simulations to validate intrinsic reverse rate dependence consider the injection of current rather than alterations to any specific ion channels [11], [14]. It is thereby a generic property of the AP. However, this property does not preclude rate dependencies of individual currents or of the effects of perturbations to individual currents. Differing rate-dependent behavior in different currents creates the possibility for non-RRD APD prolongation despite a baseline RRD response. Furthermore, dramatic rate-dependent behavior in individual currents is likely to manifest as rate-dependent changes in the AP contour. It follows that the rate-dependent change in AP contour and the capacity for forward rate-dependence should be strongly correlated, as we found (Figure 5B). We can therefore extend and refine previous ideas [14] by noting that intrinsic reverse rate dependence can in principle be overcome if rate-dependent changes to the AP contour are sufficiently large. At a more mechanistic level, our simulations have generated new predictions about how particular perturbations lead to rate-dependent changes in APD. Although these predictions are mostly specific to particular models, they nonetheless offer new mechanistic insight. For instance, we found that enhanced ICaL density produced FRD AP prolongation in the TP06 epicardial model. By systematically examining the behavior of each major current after this perturbation (ΔQ analysis), we were able to identify the indirect, rate-dependent increase in IKs as the basis of the forward rate dependence (Figure 8). Closer examination of the APs revealed that increased ICaL raises plateau voltage at slow pacing only (Figure S1), resulting in the greatly increased activation of IKs at slow pacing. While this result may be model-specific, it demonstrates two important points. First, rate-dependent changes in plateau voltage may be an indirect strategy to achieve forward rate dependence via activation of IKs. Second, more generally, a global analysis of parameter sensitivities followed by more fine-grained simulations is an efficient method for elucidating novel and potentially counterintuitive mechanisms [15], [26], [30]. Parameters relating to IKs were the most consistently RRD across models; slowed activation of current (decreased pxs) and smaller maximal conductance (decreased GKs) ranked as the first and second most RRD perturbations, respectively, in a consensus list based on results from all models (Table 2). We investigated slowed IKs activation in the TP06 model and found that, at slow pacing, this perturbation resulted in considerably smaller peak IKs and delayed repolarization (Figure 8B). At fast pacing, however, this perturbation caused an immediate rise in IKs at the beginning of the AP (Figure 8B), and this tempered the effect of the slower activation, resulting in less AP prolongation at this rate. This occurred because slower IKs activation simultaneously retarded IKs deactivation. This in turn led, at fast rates, to accumulation of channels in the open state. This particular effect is similar to rate-dependent changes in IKs that are proposed to occur in some [9], [34] but not all species [35]–[37]. These observations, combined with the known role of IKs in repolarization reserve [26], [38]–[39] and its heightened importance in repolarization during β-adrenergic stimulation [38], [40]–[43], warrant caution when targeting this current therapeutically. The substantial capacity for forward rate dependence seen in this study appears to conflict with experimental data examining a wide range of pharmacologic agents in multiple species, which support the conclusion that reverse rate dependence is an almost universal response to diverse APD-modifying perturbations [11]–[13]. As noted above, rate-dependent changes in AP contour are the key determinant of differences in forward rate dependence capacity between models. Consistent with this idea, in the study that proposed intrinsic reverse rate dependence [11], canine AP recordings show little change in shape with pacing rate, and recordings at a slow rate (0. 2 Hz) lack the prominent phase 1 notch that we observed at the same pacing rate in the HR and FMG models. A possible reason for the discrepancy could therefore be that experimental recordings were primarily from endocardial myocytes whereas the HR [22] and FMG [21] models were developed to represent epicardial and midmyocardial myocytes, respectively. Prior experimental studies show that canine epicardial cells exhibit larger rate-dependent changes in AP contour than endocardial cells [44], and our simulations predict that reverse rate dependence would be less universal in these myocytes. These findings point to the need for additional experiments to determine whether the degree of intrinsic reverse rate dependence varies between cells isolated from different transmural layers. The comparison of particular parameters between models (Figure 6) and the consensus list of parameter rate-dependences (Table 2) suggest additional targets that should be tested to determine whether they produce FRD or RRD AP prolongation. In particular, the simulations suggest that inhibition of either IK1 or INaK can produce FRD behavior in several models. The high rank of Na+-K+ ATPase is consistent with recent studies demonstrating the importance of this current in determining rate-dependent AP shortening in ventricular myocytes [20], [45], as recently reviewed [46], but the potential for therapeutic interventions to produce beneficial AP prolongation has not been thoroughly explored. These examples again illustrate how a systematic analysis of models can suggest novel and perhaps unexpected experimental tests. The limitations of this study offer suggestions for future research that can provide additional insight into rate-dependent AP prolongation. One limitation is that our regression-based sensitivity analysis implicitly assumes that linear relationships between parameters and model outputs are reasonably accurate. Although our calculations demonstrated that this approximation describes the behavior of our virtual populations quite well (Table 1), non-linear effects may need to be considered when simulating either particular parameter combinations or more extreme changes to parameters. A second limitation is that we examined isolated cell models at steady-state pacing. This strategy allowed us to elucidate a fundamental relationship between the AP contour and the propensity for FRD or RRD changes. To examine how perturbations influence the rate-dependence of proarrhythmia biomarkers such as dispersion of repolarization between transmural layers, simulations would have to be performed with a multicellular model. For instance, Sadrieh et al. used a similar sensitivity analysis approach to examine how ionic conductances influence metrics derived from a simulated pseudo-electrocardiogram [47]; this strategy can be extended to search for perturbations that affect tissue-level biomarkers with desirable rate dependence. A third limitation is that we did not consider the effects of β-adrenergic stimulation, which almost always accompanies a physiological increase in heart rate. In addition to increasing heart rate via its effects on the sinoatrial node, β-adrenergic stimulation modulates several ionic currents in ventricular cells [43], [48]. This alters the rate dependence of the APD in a manner that is dependent on AP contour and the rate dependencies of specific underlying currents [49]–[50]. Therefore, the rate-dependent effects of at least some perturbations, particularly those that alter IKs and ICaL, are likely to change in the context of β-adrenergic stimulation. Fourth, we have modeled each perturbation as either a decrease in a maximum rate of ion transport, a voltage-independent change in gating kinetics, or a shift in steady-state activation or inactivation along the voltage axis. We have not considered the fact that the interaction of a drug with a channel may itself be rate dependent due to the fact that drugs bind to some channel states more strongly than to other states [51]–[52]. In future studies it would be interesting to investigate how these effects conspire with the cellular-level effects we have identified to make particular drugs either more FRD or more RRD. Despite these limitations, our study provides novel insight into the clinically-relevant phenomenon of RRD AP prolongation in ventricular myocytes. FRD prolongation can be produced if a perturbation causes indirect effects to other ionic currents that have appropriate rate-dependent properties. Additionally, a myocyte' s capacity for FRD prolongation depends on the extent to which its AP contour changes with rate. More generally, the study illustrates the benefits of the computational approach we have taken. As this work and other recent studies have shown, significant advantages can be gained by evaluating parameter sensitivities thoroughly [47], [53]–[54] and by comparing results from multiple models [33], [52]. Examining models comprehensively provides a wealth of predictions and allows for the identification of counterintuitive behaviors. Moreover, systematic comparisons between models can provide novel insights into mechanisms underlying divergent behaviors. Such modeling strategies will undoubtedly lead to additional breakthroughs in the future.
We conducted the rate-dependent parameter sensitivity analysis in 7 ventricular cell models, representing human, canine, and guinea pig myocytes. The complete set of models examined is as follows: ten Tusscher, Noble, Noble & Panfilov (TNNP04) [18], ten Tusscher & Panfilov (TP06) [19], O' Hara, Virag, Varro, & Rudy, (OVVR) [20], Fox, McHarg, & Gilmour (FMG) [21], Hund & Rudy (HR) [22], Luo & Rudy Phase 1 (LR91) [23], and Livshitz & Rudy (LR09) [17]. Additionally, in each human model (TNNP04, TP06, and OVVR), we conducted the analysis on each of the 3 myocardial transmural tissue layers: epicardial, mid-myocardial, and endocardial. Model formulation changes that differentiate tissue layers include several parameter baseline values and channel gating variables (see Tables S6c, S7c, and S8c in Text S1). All models were implemented in MATLAB (The MathWorks, Natick, MA) and numerically integrated using a solver for stiff systems (ode15s). At the beginning of each simulation, the cell was allowed to rest for 30–60 s before the stimulus was applied at regular intervals (2 Hz or 0. 2 Hz) until steady state was reached. Pacing rate and model formulation could have dramatic effects on the number of stimuli required to reach steady state. Text S1 describes the algorithms that were used to determine steady state conditions in each model. Table S1 in Text S1 describes how many stimuli were necessary to reach steady state conditions in each model. To determine the influence of each parameter on the action potential duration (APD), we performed a multivariable regression analysis, as described elsewhere [15], [25]. For each model at each pacing rate, we ran 300 trials, each with a different set of randomly varied parameters. Three categories of parameters were varied: (1) maximum conductance and rates of ion transport (G and K), (2) “p” values that scale gating time constants, and (3) voltage shifts, which determine the voltage dependencies of gating. Definitions of all parameters and baseline values can be found in Tables S2–S8 in Text S1. For parameter types “G”, “K”, and “p, ” each random set was generated by multiplying the baseline value of each parameter by a log-normally distributed pseudorandom scale factor. The scale factors had median of 1 and the log-transformed scale factors had a standard deviation (σ) of 0. 1 (FMG, LR91, TNNP04, TP06) or 0. 1823 (HR, OVVR, LR09), meaning that about 95% of parameters are between 82–122% (σ = 0. 1) or 70–144% (σ = 0. 1823) of control. Parameter type “V”, is an additive rather than a multiplicative factor, so each pseudorandom set was generated from a normal distribution with a mean of 0 and a standard deviation of 2 mV. Trials that displayed AP alternans, APs that failed to repolarize, or an APD more than 3 standard deviations from the mean were removed from the population before regression analysis. From each population of 300, we removed an average of 3. 38 trials (range = 0–25). The regression analysis generates a matrix of parameter sensitivities, B, such that changes in model outputs (Y) can be approximated as the change in parameters (X) times B (i. e. , Ŷ = XB≈Y). For each parameter, if B is positive, increasing the parameter prolongs the APD, and if B is negative, decreasing it prolongs the APD. Bfast and Bslow are the parameter sensitivities calculated at fast and slow pacing. When the regression is initially performed, parameter sensitivities are defined relative to the standard deviation of the log-transformed output, i. e. the variability in APD across the simulated population. In order to directly compare results obtained with fast and slow pacing, we scale the values in Bfast by the ratio of the two output standard deviations. In other words, each value is multiplied by σAPD, fast/σAPD, slow, and this allows for a direct comparison between the parameter sensitivities obtained at the two rates. A vector that we call BRD quantifies the rate dependence how each parameter influences APD. If Bslow and Bfast have the same sign, (1) Parameters for which |Bslow|>|Bfast| have a larger effect on the APD at slow pacing, and thus are RRD and are assigned a positive BRD. Parameters for which |Bslow|<|Bfast| have a larger effect on the APD at fast pacing, and thus are FRD and are assigned a negative BRD. If Bslow and Bfast have opposite signs, (2) All parameters with opposite signs of Bslow and Bfast are assigned a negative BRD value because they can be perturbed in such a way as to lengthen the APD at fast but not at slow pacing. For example, if Bfast is positive and Bslow is negative, increasing this parameter will lengthen the APD at fast pacing and shorten it at slow. Conversely, if Bfast is negative and Bslow is positive, decreasing this parameter will lengthen the APD at fast pacing and shorten it at slow. In either case, it is possible to achieve the desired outcome of preferential AP prolongation at fast pacing. The threshold for rate dependence was set at 0. 01, so BRD>0. 01 was considered RRD, BRD<−0. 01 was considered FRD, and −0. 01 ≤BRD≤0. 01 was defined as NRD. To quantify rate-dependent AP morphology change, we calculated the root mean square deviation (RMSD) between the AP time-course at fast and at slow pacing for each model, as described in Text S1. AP time courses were obtained under baseline, steady-state conditions. To directly compare the shorter APs obtained at fast rates with the longer APs seen at slow rates, fast AP time courses were rescaled with respect to time prior to the RMSD calculation. The two waveforms compared therefore had identical APD.
Several drugs intended to treat cardiac arrhythmias have failed because of unfavorable rate-dependent properties. That is, the drugs fail to alter electrical activity at fast heart rates, where this would be beneficial, but they do affect electrical activity at slow rates, where this is unwanted. In targeted studies, several agents have been shown to exhibit these unfavorable properties, suggesting that these rate-dependent responses may be intrinsic to ventricular muscle. To determine whether drugs with desirable rate-dependent properties could be rationally designed, we performed comprehensive and systematic analyses of several heart cell models. These analyses calculated the rate-dependent properties of changes in any model parameter, thereby generating simultaneously a large number of model predictions. The analyses showed that targets with favorable rate-dependent properties could indeed be identified, and further simulations uncovered the mechanisms underlying these behaviors. Moreover, a quantitative comparison of results obtained in different models provided new insight in why a given drug applied to different species, or to different tissue types, might produce different rate-dependent behaviors. Overall this study shows how a comprehensive and systematic approach to heart cell models can both identify novel targets and produce more general insight into rate-dependent alterations to cardiac electrical activity.
systems biology
medicine and health sciences
biology and life sciences
computational biology
cardiology
Comprehensive Analyses of Ventricular Myocyte Models Identify Targets Exhibiting Favorable Rate Dependence